On August 1, 2024, Novo Holdings, a leading international life science investor, announced a £50 million investment in Oxford Nanopore Technologies, a leading UK-listed company behind a new generation of molecular sensing technology based on nanopores, which is today used for DNA/RNA sequencing. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on IP diligence matters related to the transaction.

The Wilson Sonsini team that advised Novo Holdings on IP matters related to the transaction includes Jing Wang, Kelsey MacConaghy, Alex Turner, Joseph Lesniewski, Shu Wang, and Ali Alemozafar.

For more information, please see Novo Holdings’ press release.